Evotec SE
EVT DE0005664809
Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. As of 31 December 2021 Evotec had a market capitalization of 7.5 billion and a pipeline of more than 130 partnered programs in discovery, pre-clinical development and clinical development.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 37% | -17% | 5% | 14% | 1% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Hitchin, Paul DIR |
5.91 EUR |
12,500 Bought |
73,875 EUR |
16/09/2025 | 12/09/2025 |
| Hitchin, Paul DIR |
5.91 EUR |
12,500 Bought |
73,875 EUR |
16/09/2025 | 12/09/2025 |
| Wojczewski, Dr. Christian DIR |
5.92 EUR |
49,984 Bought |
295,905 EUR |
28/08/2025 | 27/08/2025 |
| Wojczewski, Dr. Christian DIR |
6.11 EUR |
9,998 Bought |
61,087 EUR |
13/09/2024 | 13/09/2024 |
| Dalbiez, Aurélie DIR |
6.03 EUR |
3,500 Bought |
21,102 EUR |
05/09/2024 | 05/09/2024 |
| Wojczewski, Dr. Christian DIR |
6.45 EUR |
9,995 Bought |
64,466 EUR |
02/09/2024 | 02/09/2024 |
| Löw-friedrich, Prof. Dr. Iris DIR |
6.67 EUR |
15,000 Bought |
100,050 EUR |
29/08/2024 | 28/08/2024 |
| Wojczewski, Dr. Christian DIR |
5.66 EUR |
20,016 Bought |
113,291 EUR |
26/08/2024 | 23/08/2024 |
| Johnstone, Dr. Craig DIR |
5.52 EUR |
2,999 Bought |
16,553 EUR |
22/08/2024 | 22/08/2024 |
| Wojczewski, Dr. Christian DIR |
5.98 EUR |
9,994 Bought |
59,766 EUR |
19/08/2024 | 16/08/2024 |